Basal epithelial stem cells are efficient targets for prostate cancer initiation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 6, 2010, Pages 2610-2615

  Lawson, Devon A ^a   Zong, Yang ^a   Memarzadeh, Sanaz ^b   Xin, Li ^c   Huang, Jiaoti ^b   Witte, Owen N ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AKT; AR; CD49F; ERG; ETS

Indexed keywords

ALPHA6 INTEGRIN; ATAXIN 1; FIBROBLAST GROWTH FACTOR; PROTEIN KINASE B; TRANSCRIPTION FACTOR ERG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; EPITHELIUM BASAL CELL; EPITHELIUM HYPERPLASIA; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE CANCER; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 10; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, SCID; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEIN C-FLI-1; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ANDROGEN; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELLS;

MURINAE;

EID: 77249178726     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913873107     Document Type: Article

References (38)

1. Carson CC, 3rd (2006) Carcinoma of the prostate: overview of the most common malignancy in men. N C Med J 67:122-127.
2. Barker N, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457:608-611.
3. Huntly BJ, et al. (2004) MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6:587-596.
4. Krivtsov AV, et al. (2006) Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442:818-822.
5. Cozzio A, et al. (2003) Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 17:3029-3035.
6. English HF, Santen RJ, Isaacs JT (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242.
7. Tsujimura A, et al. (2002) Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol 157:1257-1265.
8. Okada H, et al. (1992) Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch 421:157-161.
9. Zhou Z, Flesken-Nikitin A, Nikitin AY (2007) Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res 67:5683-5690.
10. Wang S, et al. (2006) Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 103:1480-1485.
11. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J (2009) Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. PLoS One 4:e5662.
12. Wang X, et al. (2009) A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 461:495-500.
13. Xin L, Ide H, Kim Y, Dubey P, Witte ON (2003) In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci USA 100 (Suppl 1):11896-11903.
14. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON (2007) Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 104:181-186.
15. Kyprianou N, Isaacs JT (1988) Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562.
16. Mirosevich J, et al. (1999) Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate. J Endocrinol 162:341-350.
17. Bonkhoff H, Remberger K (1993) Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate. Virchows Arch 422:35-38.
18. Masai M, et al. (1990) Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate 17:293-300.
19. Ellwood-Yen K, Wongvipat J, Sawyers C (2006) Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens. Cancer Res 66:10513-10516.
20. Memarzadeh S, et al. (2007) Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12:572-585.
21. Davies JA (2002) Do different branching epithelia use a conserved developmental mechanism? Bioessays 24:937-948.
22. Donjacour AA, Thomson AA, Cunha GR (2003) FGF-10 plays an essential role in the growth of the fetal prostate. Dev Biol 261:39-54.
23. Tomlins SA, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648.
24. Klezovitch O, et al. (2008) A causal role for ERG in neoplastic transformation of prostate epithelium. Proc Natl Acad Sci USA 105:2105-2110.
25. Tomlins SA, et al. (2008) Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10:177-188.
26. Zong Y, et al. (2009) ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proc Natl Acad Sci USA 106:12465-12470.
27. Mosquera JM, et al. (2007) Morphological features of TMPRSS2-ERG gene fusion prostate cancer. J Pathol 212:91-101.
28. Dahia PL (2000) PTEN, a unique tumor suppressor gene. Endocr Relat Cancer 7: 115-129.
29. Sellers WR, Sawyers CL. (2002) Somatic Genetics of Prostate Cancer: Oncogenes and Tumor Suppressors (Loppincott Wiliams & Wilkins, Philadelphia).
30. Majumder PK, et al. (2003) Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci USA 100:7841-7846.
31. Xin L, Lawson DA, Witte ON (2005) The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102:6942-6947.
32. Mulholland DJ, et al. (2009) Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model. Cancer Res 69:8555-8562.
33. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1:34-45.
34. Wen Y, et al. (2000) HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res 60:6841-6845.
35. Xin L, et al. (2006) Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc Natl Acad Sci USA 103:7789-7794.
36. Xue Y, Smedts F, Debruyne FM, de la Rosette JJ, Schalken JA (1998) Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate 34:292-301.
37. van Leenders G, Dijkman H, Hulsbergen-van de Kaa C, Ruiter D, Schalken J (2000) Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy. Lab Invest 80:1251-1258.
38. Shen MM, Wang X, Economides KD, Walker D, Abate-Shen C (2008) Progenitor cells for the prostate epithelium: roles in development, regeneration, and cancer. Cold Spring Harb Symp Quant Biol 73:529-538.